case report  
Post-radiation epithelioid angiosarcoma of the urinary bladder  
and prostate  
1
,4  
2,4  
1,4  
3,4  
Gang Wang, MD, PhD; Peter C. Black, MD; Brian F. Skinnider, MD; Malcolm M. Hayes, MB, ChB;  
Edward C. Jones, MD1  
,4  
1
2
3
Department of Pathology, Vancouver General Hospital, Vancouver, BC, Canada; Department of Urology, Vancouver General Hospital, Vancouver, BC, Canada; Department of Pathology, British Columbia  
4
Cancer Agency, Vancouver, BC, Canada; University of British Columbia, Vancouver, BC, Canada  
Cite as: Can Urol Assoc J 2016;10(5-6):E197-200. http://dx.doi.org/10.5489/cuaj.3220  
Published online May 12, 2016.  
Case report  
A 79-year-old man was treated in 2007 with external beam  
radiotherapy for prostatic adenocarcinoma. In the spring  
of 2013, he developed irritative lower urinary tract symp-  
toms and gross hematuria. Cystoscopy revealed a papil -  
lary bladder tumour, which was resected transurethrally.  
Microscopically, a widely infiltrating, poorly-differentiated  
neoplasm was identified (Fig. 1A). The tumour had epithe-  
lioid cytologic features (Fig. 1B), with areas of hemorrhage  
and spindle cell patterns (Figs. 1C, 1D). The findings were  
considered to be in keeping with a high-grade urothelial  
carcinoma with sarcomatoid dedifferentiation. Some of the  
curetted surfaces contained proliferative urothelial epithe-  
lium with a reactive polypoid/papillary hyperplasia (Fig. 1A)  
that had the potential to be misinterpreted as a noninvasive  
papillary component of urothelial carcinoma. The immu-  
nostain for cytokeratin 7 was positive in the majority of the  
tumour cells (Fig. 1E). The tumour cells were negative for  
prostate-specific antigen (PSA) and Pap on immunostaining.  
The cytokeratin 20 immunostain was positive in the surface  
urothelium and negative in the tumour cells.  
Two months following the transurethral curettage, the  
patient underwent radical cystoprostatectomy. Microscopic  
examination demonstrated an extensively invasive, high-  
grade neoplasm involving the prostate gland, both seminal  
vesicles, and bladder trigone. Multiple resection margins  
of the prostate and bladder wall were involved by invasive  
tumour. The malignancy showed a range of morphologic  
appearances, with some areas of solid and epithelioid pat-  
tern resembling a poorly differentiated carcinoma and other  
areas showing more pronounced vascular differentiation  
with anastomosing, angular, blood-filled spaces lined by  
elongated hyperchromatic tumour cells (Figs. 2A, 2B, 2C).  
Immunohistochemical stains showed expression of vascular  
markers CD31 (Fig. 2D), CD34, FLI1, and ERG (Fig. 2E) in  
the tumour cells. The tumour cells showed patchy positivity  
for cytokeratin 7. Both the prostate and bladder tumour com-  
Abstract  
Angiosarcoma of the lower urinary tract is exceedingly rare. A  
minority of cases are associated with local radiotherapy. Epithelioid  
angiosarcoma is a variant of angiosarcoma composed of large  
rounded epithelioid endothelial cells that are positive for cytokera-  
tin on immunostaining. There are only two cases of post-radiation  
epithelioid angiosarcoma reported in the urinary bladder, and none  
in the prostate gland. We report a case of epithelioid angiosarcoma  
involving the urinary bladder and prostate in a patient with a his-  
tory of radiotherapy for prostatic adenocarcinoma. A brief review  
of literature regarding post-radiation epithelioid angiosarcomas in  
the lower urinary tract is discussed.  
Introduction  
Angiosarcoma of the lower urinary tract is exceedingly rare.  
In the urinary bladder, only 34 cases have been reported  
in the English literature, 13 of which were associated with  
local radiation therapy. There are only 14 reported cases  
of angiosarcoma of the prostate, five of which were associ-  
ated with radiation therapy.  
Epithelioid angiosarcoma is a variant of angiosarcoma  
composed of large rounded epithelioid endothelial cells  
1
-6  
7
-13  
1
4
that are positive for cytokeratin on immunostaining. There  
are 12 reported cases of epithelioid angiosarcoma of the  
bladder, only two of which were associated with previous  
2
,6,15,16  
radiation.  
To the best of our knowledge, epithelioid  
angiosarcoma of the prostate gland has not been previously  
reported. It is important to be aware of epithelioid angiosar-  
coma, as its histologic appearance and positive cytokeratin  
14  
immunostain may mimic a poorly differentiated carcinoma.  
We report a case of epithelioid angiosarcoma involving  
the urinary bladder and prostate in a patient with a history  
of external beam radiation for prostatic adenocarcinoma.  
CUAJ • May-June 2016 • Volume 10, Issues 5-6  
2016 Canadian Urological Association  
E197  
©
Wꢀng ꢁꢂ ꢀl.  
Fig.1. (A) Hematoxylin and eosin staining of the original biopsy from cystoscopy  
showing a poorly differentiated, widely infiltrating neoplasm. Some of the  
curetted surfaces contain reactive urothelium (10X); (B) In most areas, the  
tumour had epithelioid cytologic features (10X); (C) Tumour with hemorrhagic  
changes (10X); (D) Tumour with spindle cell pattern (10X); (E) The immunostain  
for cytokeratin 7 is positive in the majority of the tumour cells (10X).  
Fig. 2. (A) Microscopic examination of the cystoprostatectomy specimen  
demonstrates an extensively invasive, high-grade neoplasm in the urinary  
bladder (4X); (B) Several areas show a poorly differentiated epithelioid  
malignancy resembling a poorly differentiated carcinoma (10X); (C) Tumour  
with more pronounced vascular differentiation, with anastomosing, angular,  
blood-filled spaces lined by elongated hyperchromatic atypical cells (10X);  
(
D) Immunohistochemical stains show strong and diffuse cytoplasmic  
expression of CD31 in the tumour cells (10X); (E) Immunohistochemical stains  
show strong nuclear expression of ERG in the tumour cells (10X).  
ponent showed 2060% of nuclear staining for c-Myc (Figs.  
3
A, 3B). The pelvic/celiac lymph node dissection showed  
one of 34 lymph nodes positive for metastatic tumour with  
extranodal tumour extension.  
Discussion  
The overlying bladder mucosa showed reactive papillary  
hyperplasia with no evidence of urothelial malignancy. A tiny  
residual focus of prostatic adenocarcinoma was found within  
the prostate gland peripheral zone with perineural invasion.  
Retrospective review of the hematoxylin and eosin (H&E)  
slides from the previous transurethral curettage showed areas  
of the tumour with a vasoformative pattern similar to that  
identified in the cystoprostatectomy specimen. A diagnosis  
of epithelioid angiosarcoma involving the urinary bladder  
and prostate gland was made.  
The patient’s postoperative recovery was complicated by  
a pelvic abscess with concomitant osteomyelitis. He had  
had prior radiation and was considered too frail for adjuvant  
chemotherapy so no further therapy was provided. He is  
currently alive without evidence of disease 20 months after  
cystoprostatectomy.  
The diagnostic criteria for radiation-induced sarcomas were  
described as: a previous history of radiotherapy with a laten-  
cy period of more than three years and development of his-  
tologically confirmed sarcoma within a previously irradiated  
1
7,18  
field.  
The present case satisfies all of the criteria for the  
radiation-induced angiosarcoma. The extensive involvement  
of both the prostate gland and inferior bladder wall made it  
difficult to determine the exact primary site of origin.  
Awareness of the histopathologic spectrum of angiosar-  
coma is important for the correct diagnosis, especially when  
dealing with small biopsy specimens. An angiosarcoma with  
predominant epithelioid features and solid patterns may lead  
to the erroneous diagnosis of a poorly differentiated carci-  
noma, as occurred in the current case. The urothelium may  
show significant post-radiation atypia, or may be reactive to  
E198  
CUAJ • May-June 2016 • Volume 10, Issues 5-6  
angiꢃꢄꢀꢅꢆꢃmꢀ ꢃf ꢂhꢁ lꢃwꢁꢅ uꢅinꢀꢅy ꢂꢅꢀꢆꢂ  
Fig. 3. (A) Immunohistochemistry for c-Myc protein expression in the tumour cells in the prostate gland (10X); (B) Immunohistochemistry for c-Myc protein  
expression in the tumour cells in urinary bladder (10X).  
the underlying malignancy and be incorrectly interpreted.  
A positive cytokeratin immunostain in the invasive tumour  
cells, if performed alone, will further contribute to misin-  
terpretation of an epithelioid angiosarcoma as a carcinoma.  
The most useful morphological characteristics to raise  
one’s suspicion of an angiosarcoma are the presence of  
blood-filled spaces of variable size and shape lined by  
atypical cells. However, this finding may be focal and  
overlooked. Therefore, an appropriate immunohistochemi-  
cal panel of stains is crucial to make the correct diagnosis.  
Due to variability of staining, more than one endothelial  
marker, including CD31, CD34, FLI1, ERG, or Factor VIII  
may be necessary to support the diagnosis. Of note, posi-  
tive ERG immunostain is known to be found in up to 50%  
The clinical features of our patient and the reported post-  
radiation epithelioid angiosarcoma are summarized in Table  
1. Compared to the recently reported cases by Matoso et al,2  
our patient had shorter interval after the previous radiation  
(six years), and much better outcome (20 months with no  
evidence of recurrence).  
In summary, primary angiosarcomas of the urinary blad-  
der and prostate gland are exceedingly rare. They may pose  
considerable diagnostic difficulty in a partial sampling, par-  
ticularly when there is a solid epithelioid pattern of growth.  
Awareness of the possibility of epithelioid angiosarcoma  
occurring in this location, particularly with a history of pel-  
vic radiation, and use of appropriate immunohistochemical  
studies are crucial to establish a correct diagnosis.  
1
9
of prostate carcinomas. Evidence of Myc amplification,  
as seen in the current case report, may be supportive, as it  
Competing interests: The authors declare no competing financial or personal interests.  
2
0
is found in over half of the post-radiation angiosarcomas.  
Table 1. Clinical features of post-radiation epithelioid angiosarcoma of the bladder and prostate  
History  
of other  
cancer  
Time after  
radiation  
(years)  
Age  
Sex  
Additional  
treatment  
Followup Vascular Epithelial  
(months) markers markers  
Additional  
studies  
Authors  
Location  
Type of surgery  
Matoso  
et al  
71  
Male  
TURB followed by  
cystoprostatectomy  
CD31+,  
FVIII+  
Bladder neck  
Right lateral  
N/A  
N/A  
Prostate  
10  
7/DOD  
6/DOD  
CK7+  
CK7+  
N/A  
N/A  
CD31+,  
FVIII+,  
CD34+  
Matoso  
et al  
85  
Male bladder wall  
TURB  
Prostate  
15  
CD31+,  
CD34+,  
FLI1+,  
ERG+  
Present  
case  
79  
Male and prostate cystoprostatectomy  
Bladder neck  
TURB followed by  
c-Myc  
amplification  
No  
Prostate  
6
20/NED  
CK7+  
DOD: dead of disease; NA: Not available; NED: no evidence of disease; TURB: transurethral resection of the bladder.  
CUAJ • May-June 2016 • Volume 10, Issues 5-6  
E199  
Wꢀng ꢁꢂ ꢀl.  
This paper has been peer-reviewed.  
11. Humphrey PA. Angiosarcoma of the prostate. J Urol 2012;187:684-5. http://dx.doi.org/10.1016/j.  
juro.2011.11.007  
1
2. Humphrey PA, American Society for Clinical Pathology. Prostate pathology Chicago: American Society  
for Clinical Pathology; 2003.  
References  
13. Khaliq W, Meyer CF, Uzoaru I, et al. Prostate angiosarcoma: A case report and literature review. Med  
Oncol 2012;29:2901-3. http://dx.doi.org/10.1007/s12032-012-0188-x  
1
4. Fletcher CDM, Unni KK, Mertens F. WHO Classification of Tumours: Pathology and Genetics of Tumours  
of Soft Tissue and Bone. Lyon: IARC Press; 2002.  
5. Abbasov B, Munguia G, Mazal PR, et al. Epithelioid angiosarcoma of the bladder: Report of a new case  
with immunohistochemical profile and review of the literature. Pathology 2011;43:290-3. http://dx.doi.  
org/10.1097/PAT.0b013e328344e2fb  
6. Warne RR, Ong JS, Snowball B, et al. Primary angiosarcoma of the bladder in a young female. BMJ Case  
Rep 2011;April 1. http://dx.doi.org/10.1136/bcr.11.2010.3484  
7. Arlen M, Higinbotham NL, Huvos AG, et al. Radiation-induced sarcoma of bone. Cancer 1971;28:1087-  
1
.
Kulaga A, Yilmaz A, Wilkin RP, et al. Epithelioid angiosarcoma of the bladder after irradiation for endo-  
metrioid adenocarcinoma. Virchows Arch 2007;450:245-6. http://dx.doi.org/10.1007/s00428-006-  
1
0
336-9  
Matoso A, Epstein JI. Epithelioid angiosarcoma of the bladder: A series of 9 cases. Am J Surg Pathol  
015;39:1377-82. http://dx.doi.org/10.1097/PAS.0000000000000444  
2.  
3.  
4.  
5.  
6.  
7.  
8.  
2
1
1
1
1
Morgan MA, Moutos DM, Pippitt CH Jr, et al. Vaginal and bladder angiosarcoma after therapeutic irradia-  
tion. South Med J 1989;82:1434-6. http://dx.doi.org/10.1097/00007611-198911000-00025  
Navon JD, Rahimzadeh M, Wong AK, et al. Angiosarcoma of the bladder after therapeutic irradiation for  
prostate cancer. J Urol 1997;157:1359-60. http://dx.doi.org/10.1016/S0022-5347(01)64980-2  
Seethala RR, Gomez JA, Vakar-Lopez F. Primary angiosarcoma of the bladder. Arch Pathol Lab Med  
9
9. http://dx.doi.org/10.1002/1097-0142(1971)28:5<1087::AID-CNCR2820280502>3.0.CO;2-F  
8. Cahan WG, Woodard HQ, et al. Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1948;1:3-  
9. http://dx.doi.org/10.1002/1097-0142(194805)1:1<3::AID-CNCR2820010103>3.0.CO;2-7  
2
2
006;130:1543-7.  
9. Mehra R, Tomlins SA, Shen R, et al. Comprehensive assessment of TMPRSS2 and ETS family gene aberra-  
tions in clinically localized prostate cancer. Mod Pathol 2007;20:538-44. http://dx.doi.org/10.1038/  
modpathol.3800769  
0. Manner J, Radlwimmer B, Hohenberger P, et al. Myc high-level gene amplification is a distinctive feature  
of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 2010;176:34-9. http://dx.doi.  
org/10.2353/ajpath.2010.090637  
Tavora F, Montgomery E, Epstein JI. A series of vascular tumors and tumour-like lesions of the bladder.  
Am J Surg Pathol 2008;32:1213-9. http://dx.doi.org/10.1097/PAS.0b013e31816293c5  
Williams S, Romaguera R, Kava B. Angiosarcoma of the bladder: Case report and review of the literature.  
ScientifcWorldJournal 2008;8:508-11. http://dx.doi.org/10.1100/tsw.2008.79  
Campschroer T, van der Kwast TH, Jonges GN, et al. Angiosarcoma of the prostate: A more frequent  
finding in the future owing to radiotherapy? A literature review with treatment implications based on a  
case report. Scand J Urol 2014;48:420-5. http://dx.doi.org/10.3109/21681805.2014.905632  
Chandan VS, Wolsh L. Postirradiation angiosarcoma of the prostate.Arch Pathol Lab Med 2003;127:876-8.  
2
9
.
Correspondence: Dr. Edward Jones, Department of Pathology, Vancouver General Hospital,  
Vancouver, BC, Canada; edward.jones@vch.ca  
1
0. Guo CC, Pisters LL, Troncoso P. Prostate cancer invading the rectum: A clinicopathological study of 18  
cases. Pathology 2009;41:539-43. http://dx.doi.org/10.1080/00313020903071611  
E200  
CUAJ • May-June 2016 • Volume 10, Issues 5-6